Equillium Inc (EQ)
1.52
-0.11
(-6.75%)
USD |
NASDAQ |
Apr 30, 16:00
1.53
+0.01
(+0.66%)
After-Hours: 20:00
Equillium Price to Book Value: 2.390 for April 30, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 2.546 |
| April 26, 2024 | 2.671 |
| April 25, 2024 | 2.827 |
| April 24, 2024 | 2.796 |
| April 23, 2024 | 2.686 |
| April 22, 2024 | 2.577 |
| April 19, 2024 | 2.514 |
| April 18, 2024 | 2.702 |
| April 17, 2024 | 2.796 |
| April 16, 2024 | 2.889 |
| April 15, 2024 | 2.764 |
| April 12, 2024 | 2.889 |
| April 11, 2024 | 3.046 |
| April 10, 2024 | 2.905 |
| April 09, 2024 | 3.030 |
| April 08, 2024 | 2.999 |
| April 05, 2024 | 3.334 |
| April 04, 2024 | 3.467 |
| April 03, 2024 | 3.639 |
| April 02, 2024 | 3.405 |
| April 01, 2024 | 3.295 |
| March 28, 2024 | 3.608 |
| March 27, 2024 | 3.217 |
| March 26, 2024 | 3.217 |
| March 25, 2024 | 3.811 |
| Date | Value |
|---|---|
| March 22, 2024 | 4.404 |
| March 21, 2024 | 4.326 |
| March 20, 2024 | 4.498 |
| March 19, 2024 | 4.201 |
| March 18, 2024 | 4.123 |
| March 15, 2024 | 3.967 |
| March 14, 2024 | 3.983 |
| March 13, 2024 | 4.108 |
| March 12, 2024 | 3.951 |
| March 11, 2024 | 3.951 |
| March 08, 2024 | 4.17 |
| March 07, 2024 | 4.232 |
| March 06, 2024 | 3.530 |
| March 05, 2024 | 3.498 |
| March 04, 2024 | 3.483 |
| March 01, 2024 | 3.904 |
| February 29, 2024 | 3.889 |
| February 28, 2024 | 4.061 |
| February 27, 2024 | 3.904 |
| February 26, 2024 | 4.342 |
| February 23, 2024 | 3.967 |
| February 22, 2024 | 4.061 |
| February 21, 2024 | 3.904 |
| February 20, 2024 | 4.685 |
| February 16, 2024 | 4.311 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5704
Minimum
May 09 2023
15.16
Maximum
Jul 13 2020
1.894
Average
1.741
Median
Dec 23 2021
Price to Book Value Benchmarks
| Janux Therapeutics Inc | 8.551 |
| Retractable Technologies Inc | 0.3204 |
| Mersana Therapeutics Inc | 10.42 |
| Spero Therapeutics Inc | 0.7210 |
| Vera Therapeutics Inc | 21.16 |
Price to Book Value Related Metrics
| PS Ratio | 1.472 |
| Price | 1.52 |
| Earnings Yield | -25.49% |
| Market Cap | 53.94M |